23 related articles for article (PubMed ID: 6157743)
1. Purification of immunoprotective tumor antigens by preparative isotachophoresis.
Saunders TL; Kahan BD; Pellis NR
Cancer Immunol Immunother; 1983; 16(2):101-8. PubMed ID: 6559101
[TBL] [Abstract][Full Text] [Related]
2. The effect of purification on the immunogenicity of tumor-specific transplantation antigens.
Saunders TL; Kahan BD; Pellis NR
Cancer Immunol Immunother; 1985; 19(1):22-7. PubMed ID: 3844971
[TBL] [Abstract][Full Text] [Related]
3. Carrier and adjuvant properties of liposome-borne tumor-specific antigens.
LeGrue SJ
Cancer Immunol Immunother; 1984; 17(2):135-41. PubMed ID: 6565518
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to a solubilized tumor-associated membrane antigen (TAMA) from the murine Lewis lung tumor.
McKolanis JR; Veltri RW
Cancer Immunol Immunother; 1983; 15(2):131-7. PubMed ID: 6409392
[TBL] [Abstract][Full Text] [Related]
5. Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigen.
Tanaka T; Yamagishi H; Pellis NR; Kahan BD
Cancer Immunol Immunother; 1982; 13(1):48-52. PubMed ID: 6760958
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of immunogenic and suppressogenic epitopes in tumor cells and various types of macromolecules.
Naor D
Cancer Immunol Immunother; 1983; 16(1):1-10. PubMed ID: 6196105
[No Abstract] [Full Text] [Related]
7. Noncytolytic extraction of cell surface antigens using butanol.
LeGrue SJ
Cancer Metastasis Rev; 1985; 4(3):209-19. PubMed ID: 3907820
[TBL] [Abstract][Full Text] [Related]
8. Active specific chemoimmunotherapy of lymph-node metastasis from a poorly immunogenic murine fibrosarcoma.
Naito K; Oka T; Nomi S; Yamagishi H; Kahan BD
Jpn J Cancer Res; 1989 Nov; 80(11):1119-26. PubMed ID: 2514172
[TBL] [Abstract][Full Text] [Related]
9. Extraction of a murine tumor-specific transplantation antigen with 1-butanol. I. Partial purification by isoelectric focusing.
LeGrue SJ; Kahan BD; Pellis NR
J Natl Cancer Inst; 1980 Jul; 65(1):191-6. PubMed ID: 6930513
[TBL] [Abstract][Full Text] [Related]
10. Specific tumor immunity induced with soluble materials: restricted range of antigen dose and of challenge tumor load for immunoprotection.
Pellis NR; Kahan BD
J Immunol; 1975 Dec; 115(6):1717-22. PubMed ID: 52676
[TBL] [Abstract][Full Text] [Related]
11. Delayed hypersensitivity to crude and partially purified murine tumor-specific transplantation antigens and alloantigens utilizing the footpad swelling assay.
Macek CM; Kahan BD; Pellis NR
J Immunol; 1980 Oct; 125(4):1639-43. PubMed ID: 6157743
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
LeGrue SJ; Pellis NR; Riley LB; Kahan BD
Cancer Res; 1985 Jul; 45(7):3164-72. PubMed ID: 2408745
[TBL] [Abstract][Full Text] [Related]
13. Immunobiological properties of 1-butanol-extracted cell surface antigens.
LeGrue SJ; Allison JP; Macek CM; Pellis NR; Kahan BD
Cancer Res; 1981 Oct; 41(10):3956-60. PubMed ID: 7026027
[TBL] [Abstract][Full Text] [Related]
14. Noncytolytic extraction of murine tumor-specific transplantation antigens with the nonionic detergent octyl-beta-D-glucopyranoside.
LeGrue SJ; Macek CM; Kahan BD
J Natl Cancer Inst; 1982 Jul; 69(1):131-6. PubMed ID: 6954305
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
